Moscvin M - Search Results

1

Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Ho M, Patel A, Goh CY, Moscvin M, Zhang L, Bianchi G. Ho M, et al. Among authors: moscvin m. Leukemia. 2020 Dec;34(12):3111-3125. doi: 10.1038/s41375-020-01051-x. Epub 2020 Oct 12. Leukemia. 2020. PMID: 33046818 Review.

2

Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment.

Chen T, Moscvin M, Bianchi G. Chen T, et al. Among authors: moscvin m. Front Oncol. 2020 Nov 5;10:608815. doi: 10.3389/fonc.2020.608815. eCollection 2020. Front Oncol. 2020. PMID: 33251153 Free PMC article. Review.

3

[No title available]

[No authors listed] [No authors listed] PMID: 34238761

4

ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment.

Bianchi G, Czarnecki PG, Ho M, Roccaro AM, Sacco A, Kawano Y, Gullà A, Samur AA, Chen T, Wen K, Tai YT, Moscvin M, Wu X, Camci-Unal G, Da Vià MC, Bolli N, Sewastianik T, Carrasco RD, Ghobrial IM, Anderson KC. Bianchi G, et al. Among authors: moscvin m. Blood Cancer Discov. 2021 Jul;2(4):338-353. doi: 10.1158/2643-3230.BCD-20-0164. Blood Cancer Discov. 2021. PMID: 34268498 Free PMC article.

5

Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival.

Chen T, Ho M, Briere J, Moscvin M, Czarnecki PG, Anderson KC, Blackwell TK, Bianchi G. Chen T, et al. Among authors: moscvin m. Blood Adv. 2022 Jan 25;6(2):429-440. doi: 10.1182/bloodadvances.2020003820. Blood Adv. 2022. PMID: 34649278 Free PMC article.

6

Overcoming drug resistance by targeting protein homeostasis in multiple myeloma.

Moscvin M, Ho M, Bianchi G. Moscvin M, et al. Cancer Drug Resist. 2021;4(4):1028-1046. doi: 10.20517/cdr.2021.93. Epub 2021 Dec 2. Cancer Drug Resist. 2021. PMID: 35265794 Free PMC article.

7

Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.

Ho M, Moscvin M, Low SK, Evans B, Close S, Schlossman R, Laubach J, Prada CP, Glotzbecker B, Richardson PG, Bianchi G. Ho M, et al. Among authors: moscvin m. Leuk Lymphoma. 2022 Oct;63(10):2403-2412. doi: 10.1080/10428194.2022.2084729. Epub 2022 Jun 14. Leuk Lymphoma. 2022. PMID: 35699975 Free PMC article.

8

Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy.

Moscvin M, Liacos CI, Chen T, Theodorakakou F, Fotiou D, Hossain S, Rowell S, Leblebjian H, Regan E, Czarnecki P, Bagnoli F, Bolli N, Richardson P, Rennke HG, Dimopoulos MA, Kastritis E, Bianchi G. Moscvin M, et al. Blood Cancer J. 2023 Feb 27;13(1):31. doi: 10.1038/s41408-023-00802-0. Blood Cancer J. 2023. PMID: 36849497 Free PMC article.

9

Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs.

Liu X, Moscvin M, Oh S, Chen T, Choi W, Evans B, Rowell SM, Nadeem O, Mo CC, Sperling AS, Anderson KC, Yaqoob Z, Bianchi G, Sung Y. Liu X, et al. Among authors: moscvin m. Clin Exp Med. 2023 Nov;23(7):3821-3832. doi: 10.1007/s10238-023-01124-y. Epub 2023 Jul 8. Clin Exp Med. 2023. PMID: 37421589 Free PMC article.

10

CD38 as an immunotherapeutic target in multiple myeloma.

Bonello F, D'Agostino M, Moscvin M, Cerrato C, Boccadoro M, Gay F. Bonello F, et al. Among authors: moscvin m. Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov 13. Expert Opin Biol Ther. 2018. PMID: 30394809 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page